Prostate cancer has a low number of tumor-infiltrating lymphocytes, although with a predominance of CD4+ Tregs and M2 macrophages as opposed to CD8+ T lymphocytes and natural killer (NK) cells. The gene discussed is CD8A; the disease is prostate cancer.